Source: International Congress 2014 – Acute pulmonary embolism
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Ozsu, H. Bektas, Y. Abul, T. Ozlü (Trabzon, Turkey). Combination of sPESI and cardiac troponin in the outpatient treatment of pulmoner thromboembolism. Eur Respir J 2014; 44: Suppl. 58, 2391

Member's Comments

No comment yet.

Related content which might interest you: Prognosis factors of recurrent pulmonary thromboembolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Epoprostenol dosing by concomitant therapies in the PROSPECT registry Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Rivaroxaban for treatment of venous thromboembolism. A real-life perspective in 103 patients Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Is serum cystatin C a predictor of acute pulmonary thromboembolism in patients with normal renal function? Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 HbA1c-levels in patients with operable chronic thromboembolic pulmonary hypertension Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 An overview of thrombolytic treatment for pulmonary embolism: A single center experience Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Serum apelin 13 levels in patients with pulmonary embolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Comparision of catheter-directed therapy with the systemic thrombolysis for the treatment of acute pulmonary embolism with right ventricular dysfunction Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Prognostic value of TDI assessment of right ventricular function in patients with acute pulmonary embolism Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Warfarin-associated intracranial hemorrhage during anticoagulation therapy Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Non-invasive cardiac output assessment in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Improving the safety of right heart catheterisation in sickle cell disease Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Usefulness of NT-proBNP dosage during the follow-up of PAH: Comparison with 6MWD Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Exercise-induced pulmonary hypertension in patients with systemic sclerosis: Pilot-study Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Relevance of echocardiographic composite index to improve the detection of pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Would RDW be a prognostic factor in pulmonary arterial hypertension? Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Alteration of factors associated with coagulation in provoked pulmonary embolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Outcomes in embolisations of pulmonary arterio-venous malformations Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Risk factors of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014